Neither the Ruthenium Red-stimulated efflux nor its inhibition by Nupercaine can be directly attributed to effects on mitochondrial stability. 3. Nupercaine perturbs the steady-state external Ca2+ concentration in the absence of Ruthenium Red to an extent that is explicable in terms of the inhibition of Ca2+ efflux. 4 . Various factors that are likely to be involved in determining steady-state extra-mitochondrial Ca2+ concentrations are discussed.
There have been several reports (e.g. Cronipton et al., 1976) suggesting that mitochondria, in addition to the well-documented mechanism for Ca2+ uptake, have a separate route for Ca2+ efflux. The Na+-stimulated Ca2+ efflux found in many types of mammalian mitochondria is absent from liver mitochondria (Crompton et al., 1978) . However, many workers have found that when Ruthenium Red, a potent inhibitor of Ca2+ uptake (Moore, 1971; Reed & Bygrave, 1974) , is added to rat liver mitochondria which are in a steady state with respect to external Ca2+ concentration, there is an efflux of Ca2+ from the mitochondria (Stucki & Ineichen, 1974; Puskin et al., 1976; Pozzan et al., 1977; Crompton et al., 1978) . This finding lends support to the idea that there is an efflux mechanism with a different thermodynamic driving force from that for uptake. Ca2+-phosphate symport (Lotscher et al., 1979) and Ca2+-H+ antiport (Fiskum & Lehninger, 1979) have been suggested as candidates for the efflux mechanism. Nicholls (1978b) has produced convincing evidence that the distribution of Ca2+ between intraand extra-mitochondrial space for liver mitochondria is a steady state, rather than a thermodynamic equilibrium. The extra-mitochondrial Ca2+ concentration was found to be essentially constant over a wide range of Ca2+ loads and membrane potentials. Since Ruthenium Red was not used in these investigations, the possibility of artefacts being introduced by the presence of the inhibitor was avoided. However, it remains to be established as to whether or not the Ca2+ efflux observed after Ruthenium Red addition is the same as the efflux Vol. 188 pathway, which is implied by the results of Nicholls (1978b) . We have shown that some local anaesthetics, in particular Nupercaine and Tetracaine, inhibit the Ca2+ effiux observed after Ruthenium Red addition in the steady state (Dawson et al., 1979) , and are therefore potentially useful in the investigation of the efflux pathway. Local anaesthetics, apart from their stimulatory action on mitochondrial Ca2+ uptake (Mela, 1968 (Mela, , 1969 , are known to enhance mitochondrial stability (Scarpa & Lindsay, 1972; Aleksandrowicz et al., 1973) , which is very probably due to inhibition of endogenous phospholipase A (Seppala et al., 1971; Scherphof et al., 1972) . If a fraction of the mitochondrial population were losing their integrity, and hence their matrix Ca2+, during the time course of the experiment, this would be observed either as an effect on the extra-mitochondrial steady-state Ca2+ concentration, as the released Ca2+ redistributed into the remaining intact mitochondria, or as a net efflux if re-uptake was blocked by Ruthenium Red. It is thus important to assess the stability of the mitochondria under the experimental conditions used to study the efflux pathway, and to examine the effects of local anaesthetics on this stability.
We report here some findings which suggest that the inhibition of Ca2+ efflux by Nupercaine is not directly related to effects on the stability of the mitochondria. We also show that, as well as inhibiting Ruthenium Red-promoted efflux, Nupercaine causes a decrease in the steady-state external Ca2+ concentration maintained by mitochondria. This indicates that the efflux observed after Ruthenium Red addition is unlikely to be an artefact produced by the inhibitor and is related to the efflux under steady-state conditions observed by Nicholls (1978b (Scarpa, 1975) . The instrument used was an Aminco-Chance dual-wavelength spectrophotometer equipped with a stirred circular cuvette of 1 cm diameter. The overall mixing and response time was approx. 0.5 s. The absorbance of Arsenazo III was followed at the wavelength pair 685 -665 nm. The experimental medium contained, in a volume of 5 ml: 250mM-sucrose, O0mM-Tris/HCl, pH 7.6, 2,ug of rotenone, 8pM-Arsenazo III and 0.5-2.0mg of mitochondrial protein ml-'. Subsequent additions were made with the aid of a syringe through a small hole in the lid of the cell housing. The temperature was 30°C.
Initial rates of Ca2+ uptake were measured in a medium similar to the above with the addition of 0.1 mM-HEDTA (Tris salt). CaCl2 was added to give a free Ca2+ concentration of 3.12,UM, measured with a Ca2+-sensitive electrode (Radiometer, Copenhagen, Denmark), and uptake was started by the addition of 2.5 mM-succinate (K+ salt).
Alternatively, Ca2+ uptake and efflux were followed radioisotopically, by using 45Ca2+. The experimental medium used contained, in a volume of 5 ml:
250mM-sucrose, lOmM-Tris/HCl, pH 7.6, 2,ug of rotenone, 0.5-2.0mg of mitochondrial protein-ml-' and 5pM added CaCl2, containing 0.4,uCi of 45Ca2+. ml-. After equilibration for 4min at 300C, uptake was initiated by the addition of 2.5 mmpotassium succinate. Samples (0.3ml) of the incubation mixture were centrifuged for 1 min at 15 0OOg in an Eppendorf 3200 centrifuge, followed by removal of 0.1ml samples of the supernatant for scintillation counting in 15 ml of scintillant. The scintillant used contained, in 1 litre, 4.67 g of 2,5-diphenyloxazole, 660ml of toluene and 340ml of Triton X-100. For some experiments, instead of centrifugation, the mitochondria were separated from the medium by rapidly forcing (2 s) 1 ml samples of the incubation mixture through 0.45pum Millipore filters mounted on Swinnex holders (Millipore). Samples of the filtrate were then taken for scintillation counting.
Following the observations of Dargel (1974) , mitochondria were always added to a medium already containing rotenone.
Measurement of extra-mitochondrial steady-state Ca2+ concentration. Since Nupercaine was found to produce severe interference with the Ca2+-sensitive electrode, it was necessary to adapt the Arsenazo III technique for measurement of this parameter. The incubation mixture contained, in a volume of 5 ml: 0.1 M-NaCl, 10mM-Hepes/NaOH, pH 7.0, 16juM-bovine serum albumin, 2pg of rotenone, 20,uM-Arsenazo III, 1.0mg of mitochondrial protein-ml-[, and 100,uM-Nupercaine when required.
Uptake of Ca2+ was started by the addition of 2.5 mM-succinate. CaCl2 was then added to give the required loading. When the steady state had been established, indicated by a constant value for the absorbance difference 685-665 nm, 10l1 of 20mM-EGTA (Tris salt, pH 7.0) was added. The rapid change in absorbance as residual free Ca2+ was chelated by the EGTA was taken as a measure of the free Ca2+ concentration. Calibration was by the addition of known concentrations of CaCl2 solutions (1.0 or 2.0,M final concn.) to complete reaction media supplemented with 2 nmol of Ruthenium Red. mg-' to block re-uptake of the added Ca2 .
Measurement of proton electrochemical gradient. This was measured by the method of Nicholls (1974) . The experimental medium contained, in a volume of 5 ml: 250mM-sucrose, 10mM-Tris/HCl, pH 7.6, 0.5 mM-KCI, lOpmM-86RbCl (0.025,uCi/ml), 6, jCi/ml), IOUM-P3H1-acetate (3,uCi/ml), 0.5,ug of valinomycin * ml-l, 0.4,ug of rotenone-ml-' and 2mg of mitochondrial protein ml-'. After 2min preincubation, 2.5 mM-Tris/ succinate was added. Then 150Opl samples were filtered rapidly through 0.45,um Millipore filters. The filters were placed in scintillation vials and counted for radioactivity on a Packard Tri-Carb scintillation counter as described by Nicholls (1974) . The intramitochondrial space was assumed to be 0.4pul mg of protein-' (Nicholls, 1974) .
Measurement of Ca2+ movements under the conditions of membrane-potential measurements was made by two methods. (1) The medium used for determination of membrane potential was supplemented with 8pM-Arsenazo III and movement of endogenous Ca2+ followed in the dual-wavelength spectrophotometer. (2) The radiolabelled Rb+, methylamine and acetate in the medium were replaced with an equivalent concentration of the unlabelled compounds and the mixture was supplemented with 0.27,uCi of 45CaC12 (0.5 ,uCi nmol'-)ml-1'. Extra-mitochondrial Ca2+ was determined by scintillation counting of samples of the supernatant after rapid centrifugation (15 0OOg-min).
Results
Fig . 1 shows the effect of various Nupercaine concentrations on the initial rate of Ca2+ uptake and also on Ca2+ release after Ruthenium Red addition. The results are qualitatively very similar to those previously described for Tetracaine (Dawson et al., 1979) , with 50% inhibition of efflux being obtained at approx. 80,uM-Nupercaine. The anaesthetic has very little effect on the kinetics of uptake up to a concentration of about 200pM. Above this concentration uptake is inhibited. Since these high concentrations of Nupercaine also cause swelling and release of respiratory control, the inhibition of uptake can probably be attributed to structural damage to the mitochondrial membrane. It should be noted that the starting Ca2+ concentration for the uptake experiments (3pM) was chosen such that effects either on Km or Vmax of the uptake system should have been observed.
The extent of Ca2+ efflux after Ruthenium Red addition is considerable. The data shown in Fig. 2 , in agreement with those of Crompton et al. (1978) , show that up to 50% of the accumulated Ca2+ is released within 3min of the addition of Ruthenium Red. Fig. 2 started by the addition of 2.5mM-succinate and, once uptake was complete, efflux was observed after the addition of 1.5 nmol of Ruthenium Red mg of protein-'. The kinetics of uptake (0) were followed under the same conditions, except that 0.1 mM-HEDTA (Tris salt) was present, and the starting free Ca2+ concentration was 3.1 2,M. efflux process observed on Ruthenium Red addition makes it unlikely that mitochondrial fragility is directly involved. The data of Fig. 2 would require that approx. 50% of the mitochondria break up every 3 min. However, because of the well-documented effects of Nupercaine on mitochondrial stability, it is important to establish that the mitochondria remain energetically competent over the sort of time scale used in the experiment shown in Fig. 2 and under similar conditions. Fig. 3 shows measurement of membrane potential and pH gradient in the presence and absence of Ruthenium Red and 80pM-Nupercaine. Both the total protonmotive force and the individual contributions of membrane potential and pH gradient are constant after the first 90s from the addition of substrate and are essentially unaffected by the addition of Nupercaine or Ruthenium Red. Since this experiment should measure the energy state of the whole population, it seems to rule out the possibility that the inhibition of efflux produced by Nupercaine in the presence of Ru- thenium Red is directly related to effects on mitochondrial stability. It is also apparent that the inhibition is not due to alterations in the contributions of membrane potential and pH gradient to the total protonmotive force. However, since the conditions used for membrane-potential measurements are rather different from those used previously to look at the effect of Nupercaine on Ca2+ efflux, the experiment shown in Fig. 4 (Lehninger et al., 1978) , the addition of Nupercaine causes the re-uptake of Ca2+ (Fig. 5 ). This observation is consistent with the view that Nupercaine inhibits the effiux process in the absence of Ruthenium Red. To measure the effect of Nupercaine on the steady-state Ca2+ concentration in the absence of acetoacetate it was necessary to use the conditions developed by Nicholls (1978b) . The experimental medium contained, in 5 ml: 250mM-sucrose, l0mM-Tris/HCI, pH 7.6, 1,pg of rotenone, 8,uM-Arsenazo III, 0.5 mM-potassium phosphate and 0.6mg of mitochondrial protein-ml-'. Arsenazo III absorption was followed at 685 -665 nm, and an upward deflection of the trace indicates decreasing extra-mitochondrial Ca2+ concentration. Additions: (1), 2.5 mM-potassium succinate; (2), 10guM-CaCl2; (3), 2.5 mM-lithium acetoacetate; (4), lOO,um-Nupercaine. The dashed portion of the trace shows Ca2+ movements in the absence of Nupercaine. The rapid absorbance change on addition of acetoacetate is an addition artefact.
Vol. 188 of Nupercaine, the variation of external pCa2+ with Ca2+ load is very similar to that reported by Nicholls (1978b) . The presence of 100lM-Nupercaine causes an increase in pCa2 , which varies from about 0.1 unit at low Ca2+ loads up to 0.2 unit at loadings of 70nmol mg-' and greater. Fig. 7 shows, under the same experimental conditions, the effect of Ca2+ loading on efflux rate after Ruthenium Red addition. The increase in external steady-state Ca2+ concentration with Ca2+ load is approximately coincident with the dramatic rise in efflux rate observed at Ca24 loads of over 60nmol mg-' (Fig.  7) . It also appears that inhibition of efflux by Nupercaine is greater at higher Ca2+ loads. The data in Fig. 7 show that 100,uM-Nupercaine causes a 45% inhibition of efflux at a loading of 30nmol*mg-1, but an approx. 65% inhibition at a loading of 80nmol mg-1. The shape of the curve observed in Fig. 7 is very similar to that reported by Harris et al. (1979) for rat heart mitochondria in the presence of mersalyl.
Discussion
The observations in the present paper are consistent with the view that Ca2+ efflux observed after Ruthenium Red addition to Ca2+-loaded mitochondria is a manifestation of an efflux mechanism which is operative all the time. As with mitochondria from brain and heart (Nicholls, 1978a) , efflux in the presence of Ruthenium Red takes place with no diminution in protonmotive force, so that Ca2+ loss is not dependent on mitochondrial damage. However, unlike heart and brain mitochondria, efflux from liver mitochondria does not seem to be accompanied by changes in the individual contributions of membrane potential and pH gradient. This observation would suggest that exit of Ca2+ is by an electroneutral and pH-balanced process, such as a Ca2+-(anion)2-symport. However, other ions may redistribute to maintain a constant membrane potential and ApH, so that it is unwise on the basis of this experiment to try to distinguish between Ca2+-anion symport (Lotscher et al., 1979) and Ca2+-H+ antiport (Fiskum & Lehninger, 1979) as the mechanism for efflux. The inhibition of efflux by Nupercaine cannot be ascribed directly to changes in mitochondrial fragility caused by phospholipase A activity, since the mitochondria seem to be stable in the absence of the anaesthetic. Similarly, Nupercaine, under the experimental conditions used here, has no effect on the relative contributions of membrane potential and ApH to the protonmotive force, so that changes in these parameters are unlikely to be responsible for the inhibition. Local anaesthetics are known to displace Ca2+ from mitochondrial membranes (Scarpa & Azzi, 1968) . However, there appears to be no evidence of competitive inhibition of Ca2+ efflux, as might be expected if Ca2+ were being displaced from a carrier by Nupercaine. Indeed, under these conditions, inhibition is somewhat greater at higher Ca2+ loadings. The mechanism of inhibition is thus obscure, but may reside in effects on the permeability of the mitochondrial membrane to anions (Selwyn et al., 1978) , or in effects on the loss of adenine nucleotides and Mg2+, which appear to be important factors in Ca2+ retention (AlShaikhaly & Harris et al., 1979) . A non-specific effect on membrane fluidity or thickness is a further possibility.
Whatever the mechanism of inhibition, Nupercaine perturbs the steady-state extra-mitochondrial Ca2+ concentration, as would be predicted if a Ca2+ cycle were operating (Carafoli, 1979) . Nicholls (1978b) found that the rate of Ca2+ uptake was decreased by a factor of 2 for each 0. 12 unit increase in external pCa2+. Thus it would be expected that a 50% inhibition of efflux would result in an increase of 0.12 in external pCa2 , since at this new value the rate of uptake should also be decreased by 50%. The results shown in Figs. 6 and 7 are consistent with this. A 45% inhibition of efflux (at low loading) causes a shift in pCa2+ of 0.1 unit, and a 65% inhibition (at high loading) causes a shift of 0.2 unit. The calculated values are 0.1 1 and 0.19 respectively.
It appears that a contributory factor to the decreased external pCa2+ at high loading could be the greatly increased efflux rate under these conditions (Fig. 7) . However, it is only at these high loadings that there is any relationship between the distribution ratio for Ca2+ in extra-and intramitochondrial space and mitochondrial membrane potential (Nicholls, 1978b) . This apparent anomaly would be resolved if it is assumed that the activity coefficient of intra-mitochondrial Ca2+ is not constant at different Ca2+ loadings. It is known that liver mitochondria contain binding sites for Ca2+ (see, e.g., Rossi et al., 1967) and, in addition, endogenous phosphate and bicarbonate ions will lead to intramitochondrial precipitation of Ca2+. At low Ca2+ loading, precipitation and binding of Ca2+ would result in a very small activity coefficient for accumulated Ca2+. Under these conditions, there would be apparently no dependence of accumulation ratio on membrane potential, and low efflux rates. At higher loading, when the binding sites and precipitable anions are saturated, the activity coefficient would rise rapidly, resulting in both dependence of accumulation ratio on membrane potential and enhanced effiux. Thus it would be expected that, at high loading, although the accumulation ratio might be dependent on membrane potential, it would not be in equilibrium with it, since efflux is fast under these conditions.
The value of the activity coefficient for intramitochondrial Ca2+ is likely to depend on intramitochondrial pH (Rossi et al., 1967) and will also be affected by the presence of Nupercaine (Low et al., 1979) . The external steady-state pCa2+ that will result at a given Ca2+ loading is thus dependent on these factors as well as membrane potential and efflux rate. These complexities may afford an explanation of the rather strange phenomenon shown in Fig. 7 , where, in the presence of Nupercaine, increasing the Ca2+ load from 30 to 50 nmol *mg-1 results in an increased external pCa2+.
